Anna Grodzinsky is a Cardiology physician affiliated with Saint Luke's Health System. OpenAlex indexes 84 publications with 667 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4330 Wornall Rd
Suite 2000
Kansas City, MO 64111
Telephone
816-931-1883Registry record last updated 15 Sept 2018.
Clinical trials
- The Heart Outcomes in Pregnancy Expectations (H.O.P.E) Registry
Sponsor: Saint Luke's Health System
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81%Statin15.6%Atorvastatin Calcium66%Rosuvastatin Calcium25%Simvastatin5%Pravastatin Sodium4%Part D<11 patientsBeta blocker13.9%Metoprolol Succinate42%Carvedilol42%Metoprolol Tartrate17%Part D≥70 patients+ 16 more classes in this area
Blood & clotting
12.1%Factor Xa inhibitor7.7%Eliquis86%Xarelto14%Part D≥59 patientsVitamin K antagonist2.7%Warfarin Sodium100%Part D≥21 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.9%SGLT2 inhibitor3.3%Jardiance100%Part D≥33 patientsProton pump inhibitor1.5%Pantoprazole Sodium100%Part D≥17 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sex Differences in Spontaneous Coronary Artery Dissection: A Report of the iSCAD Registry
Journal of the American Heart Association
2026 - 26-A-10941-ACC PREGNANCY ASSOCIATED SCAD: A REPORT OF THE ISCAD REGISTRY
Journal of the American College of Cardiology
2026 - Sex Differences in Psychosocial Factors and Angina in Patients With Chronic Coronary Disease
Journal of the American Heart Association
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Suzanne Arnold, MD
Saint Luke's Health System
Michael Nassif, MD
Saint Luke's Health System
Carlos Bagley, MD
Saint Luke's Health System
Adam Salisbury, MD
Saint Luke's Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”